Recent studies suggest that proarrhythmic effects of cardiac glycosides (CGs) on cardiomyocyte Ca 2+ handling involve generation of reactive oxygen species (ROS). However, the specific pathway(s) of ROS production and the subsequent downstream molecular events that mediate CG-dependent arrhythmogenesis remain to be defined.
Introduction
Cardiac glycosides (CGs) are an important class of naturally occurring drugs whose primary target is the plasma membrane Na + /K + -ATPase (NKA). 1 CGs have been traditionally used in the treatment of congestive heart failure (HF) due to their ability to increase cardiac contractility. 2 However, adverse side effects of CGs, 2 including cardiac arrhythmias, 3 remain a serious problem especially in elderly populations. 4 Digitoxin (DGT) and digoxin are the two available CGs with equal efficacy and similar toxicities. 5 A thorough understanding of the mechanisms that underlie the therapeutic and toxic effects of CGs is essential for improved therapeutic outcomes. Additionally, improved understanding of CG cardiotoxicity is likely to provide insights into myocardial diseases marked by defective intracellular Ca 2+ homeostasis.
The beneficial impact of CGs on cardiac performance has been attributed to changes in ionic balance secondary to inhibition of NKA. 1 An elevation of intracellular Na + causes accumulation of intracellular Ca 2+ thereby leading to increased myocyte contractility. 6, 7 DADs can then result in ectopic excitation and triggered activity. 8, 9 Recent studies have suggested an alternative mechanism for proarrhythmic alterations in myocyte Ca 2+ handling caused by CGs involving the generation of reactive oxygen species (ROS). 10 -12 The specific intracellular pathways leading to ROS formation, and the causal links between ROS, abnormal Ca 2+ cycling, and arrhythmias remain to be elucidated. In the present study, we examined the mechanisms of ROS production by DGT and the downstream processes behind the proarrhythmic effects of DGT in cardiac myocytes using a combination of pharmacological approaches and genetic mouse models.
Methods
Two-to-four-month-old male wild-type (WT), NADPH oxidase type 2 knockout (NOX2KO), 13 inducible mitochondrial superoxide dismutase (SOD2) overexpression, 14 and RyR2 knock-in (RyR2-S2814A) 15 
Myocyte isolation and confocal microscopy
Mouse ventricular myocytes were isolated using Liberase TH Research Grade enzyme (Roche). Confocal imaging was recorded using an Olympus Fluoview 1000 confocal microscope. See Supplementary material online for more details.
Western blotting
Samples were prepared from Langendorff-perfused intact mouse hearts, and then instantly frozen in liquid nitrogen. Cardiac homogenates were prepared and analysed by western blot. See Supplementary material online for more details.
Statistical analysis
Data are presented as mean + SE. Statistical analyses were performed using ANOVA with Tukey's post hoc test. Values of P , 0.05 were accepted as statistically significant. Figure 1 ). The frequency of SCWs was markedly decreased in NOX2KO myocytes with DGT failing to induce SCWs at high concentrations (up to 5 mM DGT; see Figure 1C ). Of note, the elevation of Ca Figure S2 ). To determine whether prevention of DGT-dependent Ca 2+ waves by NOX2 ablation is attributable to reduced ROS production, we performed ROS measurements in NOX2KO vs. WT myocytes with the ROS indicator CM-H 2 DCFDA. DGT increased ROS in WT but not in NOX2KO cells ( Figure 1D and E). Thus, NOX2 deletion prevented DGT-dependent ROS production and inhibited SCWs.
Results

DGT-dependent alterations in
To examine the possibility that ablation of NOX2 indirectly altered responsiveness of NKA to DGT, we performed control experiments with measurements of intracellular Na + accumulation in NOX2KO vs.
WT myocytes using the Na + indicator sodium green. Exposure to DGT (150 nM) led to similar increases in sodium green fluorescence in NOX2KO and WT myocytes (Supplementary material online, Figure S3 ) suggesting that NKA-dependent Na + transport activity was unaltered in NOX2KO myocytes. Thus, the observed resistance of these cells to the proarrhythmic effects of DGT was specifically attributable to the deficiency of NOX2. Since PI3K and PKC have been both implicated as components of CG signalling 19 and shown to activate NOX2 in various cell systems, 20 -22 we tested their involvement in the NOX2-dependent ROS release induced by DGT. Pre-treatment with the PI3K or PKC inhibitors, LY294002 (LY) or Bisindolylmaleimide I (BIM), respectively, prevented DGT-induced ROS release in WT myocytes ( Figure 2 ), thus suggesting a specific role for PI3K and PKC signalling in DGT-dependent NOX2 activation. Rather than acting upstream of NOX2, the epsilon isoform of PKC (PKC1) could mediate the effects of DGT downstream of NOX2, possibly via ROS-dependent activation of the mitochondrial K ATP channel 23 (see below). In order to examine this possibility, we used 1V1-2, a specific inhibitor for PKC1, as opposed to the pan PKC inhibitor BIM. As shown in Figure 2 , 1V1-2 had no significant effect on DGT-dependent ROS confirming that BIM acted upstream of NOX2.
SOD2 overexpression increases resistance to arrhythmic toxicity of DGT
The results of our pharmacological analysis suggested that besides NOX2, mitochondria may play a key role in DGT-dependent alterations in ROS and Ca 2+ handling. To verify the role of mitochondria in the observed effects of DGT, we used a doxycycline (Dox)-inducible mouse model of mitochondrial superoxide dismutase (SOD2) overexpression. Similar to WT myocytes, DGT increased the propensity for SCWs in myocytes derived from uninduced mice (SOD2Dox-) ( Figure 3 ). However, induction of SOD2 overexpression (SOD2Dox+) resulted in a reduction of DGT-dependent SCWs. The dose-response of the arrhythmogenic effects of DGT shifted markedly to higher concentrations in SOD2Dox+ myocytes ( Figure 3C) . Notably, the increase in Ca 2+ transient amplitude by DGT was preserved in these cells ( Figure 3B ). Similar to the results in WT myocytes, DGT reduced the SR Ca 2+ content in SOD2Dox-myocytes. However, overexpression of SOD2 restored SR Ca 2+ content to the control level (Supplementary material online, Figure   S2 ). Consistent with the effects of SOD2 overexpression in DGT-dependent changes in Ca 2+ handling, the rate of DGT-dependent ROS release was inhibited in SOD2Dox+ myocytes as compared to SOD2Dox-( Figure 3D and E). Thus, overexpression of SOD2 decreased proarrhythmic toxicity of DGT by reducing mitochondrial ROS release. Oxidized CaMKII and RyR2 in glycoside toxicity
NOX2 is essential for DGT-dependent mitochondrial membrane depolarization
The reliance of the proarrhythmic effects of DGT on both NOX2 and mitochondria suggests that DGT action involves interplay between these ROS generating systems. ROS release by mitochondria is associated with depolarization of the mitochondrial membrane potential (MMP). Therefore, to further elucidate the link between NOX2 and mitochondria, we performed mitochondrial membrane potential measurements by using tetramethylrhodamine ethyl ester (TMRE) in WT and NOX2KO myocytes. Application of DGT caused MMP depolarization in WT myocytes, but it failed to appreciably change MPP in NOX2KO cells ( Figure 4) . These results confirm that DGTdependent ROS release by mitochondria requires the involvement of NOX2. It is known that ROS facilitates the mitochondrial K ATP channel (mitoK ATP ) opening, 23, 24 and that, in turn opening of mitoK ATP stimulates mitochondrial ROS generation and depolarizes MMP. 25 Thus, mitoK ATP is well suited to mediate the action of NOX2-derived ROS on mitochondrial ROS release upon exposure to CGs. Consistent with a role of mitoK ATP in DGT-induced ROS release, inhibition of mitoK ATP with 5-hydroxydecanoic acid (5-HD) prevented DGT-dependent elevation of ROS in WT myocytes (Figure 2 ).
DGT causes NOX2-dependent oxidation of CaMKII and increases RyR2 phosphorylation at Ser 2814
CaMKII has emerged as an important mediator of ROS-dependent signalling in cardiac myocytes. 26 We hypothesized that CaMKII mediates the arrhythmogenic effects of DGT by phosphorylation of downstream targets including RyR2 and phospholamban (PLB). To test the hypothesis that CaMKII is involved in ROS-dependent effects of DGT on Ca 2+ handling, we first assessed oxidation of CaMKII at methionine 281/282 (ox-CaMKII) using an ox-CaMKII assay. DGT treatment significantly increased ox-CaMKII levels in WT but not in NOX2KO hearts ( Figure 5A and B) . Of note, the levels of autophosphorylation at Thr 287 were not significantly different between the groups (Supplementary material online, Figure S4 ). Thus, DGT causes CaMKII oxidation via activation of NOX2.
Next we examined whether DGT results in increased RyR2 phosphorylation by CaMKII. As shown in Figure 5C and D, DGT increased phosphorylation at Ser 2814, the primary CaMKII phosphorylation site on RyR2. Of note, there was no change in phosphorylation at Ser 2808, a site mainly phosphorylated by PKA. Similarly, DGT increased phosphorylation of PLB at Thr 17, also a target for CaMKII phosphorylation in cardiac myocytes (Supplementary material online, Figure S5 ). In contrast, RyR2 (Ser 2808 and Ser 2814) and PLB (Ser 16 and Thr 17) phosphorylation levels did not differ between control and DGT-treated NOX2KO samples, indicating that the effects of CaMKII on RyR2 and PLB require NOX2. Figure 6A and B) . Additionally, to test directly the role of RyR2 phosphorylation by CaMKII in the proarrhythmic effects of DGT, we used RyR2 knock-in mice in which CaMKII phosphorylation of RyR2 is inhibited by replacing serine at 2814 with alanine (RyR2-S2814A). As demonstrated in Figure 6A and D, ablation of the CaMKII phosphorylation site on RyR2 significantly decreased the susceptibility of DGT-treated myocytes to proarrhythmogenic Ca 2+ waves. Similar to the results obtained in SOD2Dox+ and NOX2KO myocytes, DGT did not significantly alter the SR Ca 2+ content in RyR2-S2814A myocytes (Supplementary material online, Figure S2 ). These results confirm that the arrhythmogenic effects of DGT involve phosphorylation of RyR2 by CaMKII at Ser 2814. 
Preventing RyR2 phosphorylation at
Oxidized CaMKII and RyR2 in glycoside toxicity
Apart from increasing RyR2 phosphorylation via activation of CaMKII, CG-dependent ROS could modify RyR2 directly via oxidation. Therefore, we measured the effects of DGT on the levels of RyR2 free thiols in WT and RyR2-S2814A hearts. DGT reduced free thiols to a similar level in both WT and RyR2-S2814A RyR2s (Supplementary material online, Figure S6 ). These results suggest that (i) RyR2 redox modification and phosphorylation occur in parallel in response to CGs; and (ii) enhanced RyR2 redox modification alone is not sufficient to increase myocyte arrhythmogenic propensity.
Discussion
In this study, we used a combination of pharmacological tools and genetic mouse models to investigate the mechanisms of generation of ROS as well as of subsequent actions of ROS on Ca 2+ handling that are involved in the proarrhythmic adverse effects of CGs. Our major findings are: (i) PI3K-and PKC-dependent activation of NOX2 mediates the effects of CGs, by supplying a critical source of ROS to induce further release of ROS from the mitochondria; (ii) CG-induced ROS activate CaMKII resulting in increased phosphorylation of RyR2 at Ser 2814 and proarrhythmic Ca 2+ waves.
The arrhythmogenic effects of DGT involve NOX2-dependent ROS release from mitochondria
CG-induced arrhythmias are commonly attributed to excessive accumulation of intracellular Ca 2+ , i.e. Ca 2+ overload. 27 Recently, we showed that aside from this classical mechanism, the proarrhythmic alterations in Ca 2+ handling in the presence of CGs may result from the elevation of ROS. 12 However, the specific sources of ROS, including the roles of NOX and mitochondria, as well as the molecular steps leading to their mobilization remain uncertain. The results of the present study indicate that both NOX2 and mitochondria are critical to CG-dependent ROS and arrhythmogenesis. In particular, myocytes isolated from mice deficient in NOX2 and mice overexpressing SOD2 displayed markedly increased tolerance to the proarrhythmic action of DGT as manifested by inhibition of DGT-dependent ROS and diastolic Ca 2+ waves (Figures 1 and 3) . These results complemented with those on the effects of pharmacological inhibitors of NOX and MPTP (Supplementary material online, Figure S1 ) provide unequivocal evidence for the role of these ROS generating systems in CG proarrhythmic toxicity. Oxidized CaMKII and RyR2 in glycoside toxicity
Our data also gained mechanistic insights into the interaction between NOX2 and mitochondria underlying the proarrhythmic effects of DGT. Ablation of NOX2 prevented the mitochondrial membrane depolarization caused by DGT thus placing NOX2 upstream of mitochondria as a critical mediator of mitochondrial response to DGT. Previous studies suggested the mitoK ATP might be involved in the facilitation of mitochondrial ROS release in various settings. 25, 28 Indeed, activation of mitoK ATP is reportedly ROS-dependent. 23, 24 Moreover, ROS-dependent opening of mitoK ATP can lead to the production of more ROS through depolarization of the mitochondrial membrane and uncoupling of the electron transport chain. 25 In our study, DGT-dependent ROS accumulation was sensitive to inhibition of mitoK ATP (Figure 2) , thus supporting the role of this channel in NOX2-mediated mitochondrial ROS production. The mitochondrial ROS response is likely to be further amplified by ROS-induced ROS release from a larger mitochondrial pool via MPTP. 29, 30 This could account for the relatively large magnitude of the 'global' ROS response when compared with the apparently 'local' ROS attributable to NOX2 alone that was, virtually undetectable with our cytosolic ROS indicator in myocytes overexpressing SOD2 or exposed to the mitoK ATP inhibitor, 5-HD (Figures 1, 2, and 3) . Previously, NOX-generated ROS has been shown to stimulate mitochondrial ROS production in endothelial and vascular smooth muscle cells. 31, 32 Our study shows that NOX2-derived ROS are able to induce the release of ROS from cardiac myocyte mitochondria to mediate the arrhythmogenic effects of CGs. As for the upstream signalling steps leading to NOX2 activation, our study demonstrated that ROS generation is prevented by inhibition of PI3K and PKC (but not specific inhibition of PKC1) (Figure 2) . Binding of CGs to NKA has been shown to activate Src kinase 12, 33 with a subsequent stimulation of the PI3K and PKC pathways. 19 PI3K along with PKC, on the other hand, have been linked to NOX2 activation in various systems. 20 -22 Based on the evidence presented here, PI3K and PKC mediate the NOX2-dependent oxidant production required for the arrhythmogenic action of DGT.
Oxidized CaMKII phosphorylation of RyR2 as the downstream mechanism for CG-induced ROS
CaMKII has emerged as an important integrating molecule in cardiac myocyte Ca 2+ and ROS signalling involved in various pathologies including vascular disease, heart failure, and arrhythmias. 26 Here we show that ox-CaMKII is a key mediator of the CGs ROS-induced arrhythmogenic effects on myocyte Ca 2+ handling. In particular, DGT treatment increases ox-CaMKII levels in WT (but not in NOX2KO) myocytes ( Figure 5 ). These increases in CaMKII oxidation were paralleled by increased phosphorylation of RyR2 at the CaMKII site Ser 2814. Importantly, the arrhythmogenic effects of DGT were markedly decreased in myocytes from mice lacking this site (RyR2-S2814A mice), thus providing direct evidence for the role of RyR2 CaMKII phosphorylation in the arrhythmogenic effects of DGT ( Figure 6 ). Interestingly, RyR2-S2814A myocytes along with NOX2KO myocytes displayed a higher tolerance to the proarrhythmic action of DGT than myocytes overexpressing SOD2 (Figures 1, 3, and 6 ). This difference could be ascribed to the finding that in our experimental settings, both NOX2 and RyR2 phosphorylation are required for the effects of DGT, as an essential upstream source of ROS and a critical downstream (via CaMKII) target, respectively ( Figure 7 ). SOD2 overexpression, on the other hand, only attenuates ROS produced by the mitochondria apparently without completely suppressing ROS signalling that leads to RyR2 phosphorylation at Ser 2814. The role of RyR2 CaMKII phosphorylation in DGT-induced arrhythmogenesis is consistent with previous reports showing the importance of this modification in different experimental and pathological settings including cardiac hypertrophy, non-ischaemic HF, and post-infarction sudden cardiac death. 34 As recently shown, CaMKII phosphorylation accelerates the recovery of Ca 2+ release from refractoriness, thus increasing the possibility of proarrhythmic spontaneous release. 35 It is interesting to note that DGT can also lead to oxidation of RyR2 12 (Supplementary material online, Figure S6 ). Redox modification increases RyR2 activity that in itself can also be proarrhythmic. 36, 37 Although it does not refute the potential role of RyR2 oxidation, our study demonstrates that CaMKII phosphorylation of RyR2 at Ser 2814 is essential for dysregulated Ca 2+ handling caused by DGT.
Previously, Gonano et al. 38 suggested that ouabain causes arrhythmias via Ca 2+ -dependent activation of CaMKII with subsequent phosphorylation of RyR2 leading to increased propensity for spontaneous Ca 2+ release. While reaffirming the role of CaMKII in CG toxicity, our study suggests that CaMKII activation was due, at least in part, to increased ROS and that RyR2 is a critical principal target for the pathological actions of CaMKII in the presence of DGT. Of note, consistent with the findings of Gonano et al., 38 we did observe increased phosphorylation of PLB at Thr 17 in response to DGT; however, the rate of decay of the Ca 2+ transient was unchanged suggesting that stimulation of SERCA plays a limited role in the arrhythmogenic effects of DGT under our experimental conditions.
Figure 7
The mechanism of ROS-dependent arrhythmogenic effect of DGT. Binding of digitoxin (DGT) to Na + /K + ATPase (NKA) initiates a signalling cascade that involves Src, PI3K, and PKC and NOX2 to produce ROS; ROS supplied by NOX2 induce the release of more ROS from mitochondria via activation of the mitochondrial K ATP channel (mitoK ATP ) and opening of the permeability transition pore (MPTP). DGT-induced ROS activate CaMKII in turn increasing phosphorylation of RyR2 at Ser 2814 and cause redox modifications of RyR2 thiols. NOX2, NADPH oxidase type 2; PI3K, phosphatidylinositol 3 kinase; PKC, protein kinase C; ROS, reactive oxygen species; ETC, electron transport chain; SERCA, sarcoplasmic reticulum calcium transport ATPase; SR, sarcoplasmic reticulum; RyR2, ryanodine receptor 2.
